Article: The Spirit of Radical Integration
November 2019In the Spotlight article published November 2019 by International Clinical Trials, Patricia (Patty) Leuchten, Founder and CEO of The Avoca Group, reflects on the challenges associated with managing risks and designing quality into clinical trials; the work the Avoca Quality Consortium® has done to bring together industry experts from pharma, biotech, and CROs since its creation in 2011; The Avoca Group’s latest groundbreaking venture, the Diligent® Qualification Platform, a cloud-based technology platform as a service (PaaS) solution that streamlines and simplifies provider selection and qualification; and The Avoca Innovation Alliance™, a multi-stakeholder initiative, that will bring together sponsors, CROs, and non-CRO providers to facilitate the widespread adoption of technology into clinical trials.
|
 Article taken from International Clinical Trials November 2019, pages 28-30. © Samedan Ltd |